Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says By: CNBC.com News April 25, 2023 at 13:40 PM EDT Biogen CEO Christopher Viehbacher said during an earnings call that Eli Lilly needs to consider maintenance doses its Alzheimer's treatment donanemab. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says By: CNBC.com News April 25, 2023 at 13:40 PM EDT Biogen CEO Christopher Viehbacher said during an earnings call that Eli Lilly needs to consider maintenance doses its Alzheimer's treatment donanemab. Read More >>